Novo Nordisk Aktie
| 38,50EUR | 0,36EUR | 0,94% |
WKN DE: A3EU6F / ISIN: DK0062498333
Diese Analysten bewerten die Novo Nordisk-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Deutsche Bank AG | 290,00DKK | -0,03% | 20.05.26 | |||
| Barclays Capital | 300,00DKK | 3,41% | 19.05.26 | |||
| Jefferies & Company Inc. | 270,00DKK | -6,93% | 13.05.26 | |||
| Bernstein Research | 175,00DKK | -39,68% | 12.05.26 | |||
| JP Morgan Chase & Co. | 250,00DKK | -13,82% | 08.05.26 | |||
| UBS AG | 332,00DKK | 14,44% | 08.05.26 | |||
| Goldman Sachs Group Inc. | 263,00DKK | -9,34% | 06.05.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 300,00DKK | 3,41% | 12.03.26 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|